Allocation of internal funds to working capital and capital expenditures
First written in FY2018. 3 of 9 entries say "Restated". Latest entry: FY2026.
- FY2026Updated period-end cash balanceAnnual report
「The balance of cash and cash equivalents at the end of the consolidated fiscal year was ¥11,608.5 million.」
The company continued its policy of using internal funds for working capital and capital expenditures, and cash and cash equivalents at fiscal year-end amounted to ¥11,608.5 million. - FY2026-H1Update to Cash Balance at the Interim Period-EndAnnual report
「Cash and cash equivalents at the end of the interim period: ¥109,361 million」
Cash and cash equivalents at the end of the interim period amounted to ¥10,936.1 million, an increase from ¥9,908.5 million in the same period of the previous year. - FY2025Increase in cash balance at fiscal year-endAnnual report
「The balance of cash and cash equivalents at the end of the consolidated fiscal year was ¥10,632.5 million.」
The balance of cash and cash equivalents at the end of the fiscal year increased from ¥9,988.5 million in the previous fiscal year to ¥10,632.5 million. - FY2025-H1Update to Cash Balance at the Interim Period-EndAnnual report
「Cash and cash equivalents at the end of the interim period: ¥99,085 million」
Under its policy of financing working capital and capital expenditures primarily with internal funds, cash and cash equivalents at the end of September 2024 amounted to ¥9,908.5 million. - FY2024Update to the period-end cash balanceAnnual report
「The balance of cash and cash equivalents at the end of the consolidated fiscal year was ¥9,988.5 million.」
The company continued its policy of using internal funds for working capital and capital expenditures, and disclosed year-end cash and cash equivalents of ¥9,988.5 million. - FY2023RestatedAnnual report
「The Group's policy is to fund working capital and capital investment mainly with internal funds. Cash and cash equivalents at the end of the consolidated fiscal year amounted to ¥8,665 million.」
The company reiterated its policy of financing working capital and capital investment mainly with internal funds and disclosed period-end cash and cash equivalents of ¥8,665 million. - FY2022RestatedAnnual report
「The Group's policy is to fund working capital and capital investment mainly with internal funds. Cash and cash equivalents at the end of the consolidated fiscal year amounted to ¥8,976 million.」
The company reiterated its policy of financing working capital and capital investment mainly with internal funds, and period-end cash and cash equivalents amounted to ¥8,976 million. - FY2019RestatedAnnual report
「The Group's policy is to fund working capital and capital investment mainly with internal funds. Cash and cash equivalents at the end of the consolidated fiscal year amounted to ¥8,992 million.」
The company reiterated its policy of financing working capital and capital investment mainly with internal funds, and period-end cash and cash equivalents amounted to ¥8,992 million. - FY2018First statedAnnual report
「The Group's policy is to fund working capital and capital investment mainly with internal funds. Cash and cash equivalents at the end of the consolidated fiscal year amounted to ¥7,735 million.」
The company disclosed a funding policy of financing working capital and capital investment mainly with internal funds, and period-end cash and cash equivalents of ¥7,735 million.